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The 5th International Conference on Genomics (ICG-V) 
showcased  the  latest  academic  and  technological 
advance  ments  in  genomic  research  from  international 
groups and from the BGI (formerly known as the Beijing 
Genomics  Institute;  http://www.genomics.cn/en/).  This 
3-day  conference  enabled  over  400  participants,  more 
than  20%  of  them  from  outside  mainland  China,  to 
witness scientific progress, share ideas, discuss strategies 
for  better  research,  initiate  collaborative  efforts,  and 
address urgent needs in genome research. The conference 
began with two plenary sessions on genomic perspectives 
at single or multiple levels of various biological systems. 
The plenary sessions were followed by eight concurrent 
sessions  focusing  on  key  issues  in  bioinformatics, 
genomic studies in Chinese hamster ovarian cells, human 
disorders, marine and aquaculture organisms, horticul-
tural crops, cancer, and agricultural and ecological fields.
The  motivation  remains  irresistible  to  sequence  the 
genome of all species; the emphasis on new biological 
implication  and  mechanistic  insights  was  evident  in 
almost all the reports presented. Attempts to translate 
key genomic information from such large ‘discovery or 
sequencing  driven’  projects  into  the  daily  routine,  to 
control/prevent  disease  and  improve  economical  crops 
and livestock, were more evident than in previous gather-
ings.  Second  generation  sequencing  technologies  have 
offered  monumental  improvements  in  the  production 
and accuracy of sequencing (in terms of read length, cost, 
and  ease  of  operation),  resulting  in  an  avalanche  of 
sequencing datasets. Nevertheless, matched bioinformatic 
capability is urgently required to analyze these genomic 
datasets to obtain a better biological understanding of, 
and mechanistic insights into, disease-associated genetic 
variants  and  copy  number/structural  variations.  It  is 
imperative for genomicists to respond to this urgent need 
of the biological community by offering better access to 
the ‘meaningful’ information. Related to this, a concern 
was expressed about the lack of independent validation 
of the key conclusions that were drawn in most of the 
studies reported at the meeting.
Critical genetic variants that affect the initiation and 
progression of various major diseases, including cancer, 
autoimmune  diseases,  diabetes  and  immunodeficiency 
disorders, were specifically discussed at the conference. 
Whole-genome or -exome sequencing is now preferred 
over  the  array-based  genome-wide  association  study 
(GWAS)  platform  for  identification  and  validation  of 
genetic variants of biological importance. This welcome 
move  seems  to  be  best  attributed  to  the  much  wider 
availability of affordable and enhanced sequencing capa-
bili  ties. The conceptual shift that emphasizes the role of 
rare  genetic  variants  in  the  pathology  of  the  major 
diseases  remains  to  be  widely  accepted.  Both  the 
biological  implications  and  mechanistic  interpretations 
of the epigenetic (or epigenomic) makeup of mammals 
were also stressed, in view of the fact that the epigenetic 
framework  is  more  amenable  than  DNA  sequence  to 
changing environments and directly dictates phenotypic 
diversity.
The complexity of biological systems is vividly reflected 
by  the  cellular  heterogeneity  in  gene  expression  and 
therefore  in  phenotype.  The  merit  of  the  conventional 
‘mean-of-the-sum’  approaches  to  mRNA  expression  or 
genetic diversity has been challenged by the latest single 
cell assays. Using a SOLiD sequencing platform, Fuchou 
Tang  (Peking  University,  Beijing,  China)  established  a 
global mRNA expression profile at the single-cell level. 
Both coverage and depth of reads were impressive. Tang 
reported  that  the  datasets,  having  20  million  to  100 
million  reads  from  each  of  33  individual  cells  with 
approxi  mately 60 to 80% meaningful, covered approxi-
mately 12,000 expressed genes (approximately 50% of the 
total annotated protein-coding genes). Luting Song (BGI, 
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draft single-cell genome. The present dataset consists of 
approximately  25-fold  coverage  of  80%  of  the  genome. 
Both presentations highlighted the most recent techno-
logical  refinements  and  the  potential  impact  of  such 
single-cell  genomic  approaches  on  today’s  biomedical 
research.
In addition, great advancements in the efforts aiming to 
create more robust and affordable platforms for genome 
research  were  witnessed.  Stephen  Turner  (Pacific  Bio-
sciences,  Foster  City,  USA)  described  the  striking 
improve  ments  in  sequencing  that  they  have  achieved 
using nanopore or single-molecule sequencing apparatus. 
The aspiration of completing a human genome sequen-
cing project with a budget of less than US$1,000 should 
be  achieved  much  sooner  than  previously  anticipated. 
The construction of shorter reads from second generation 
sequencing machines to make a genome draft remains 
the biggest challenge. This need seems to be satisfied, at 
least  partially,  by  the  optical  mapping  platform  with 
which the length of the fluorescence-labeled restriction 
fragments (a dozen kilobase pairs to several million base 
pairs  in  length)  can  be  measured  with  great  accuracy. 
David  Schwartz  (University  of  Wisconsin,  Madison, 
USA) described their efforts to fill the gaps left in the 
public genome databases and profile the disease-related 
gross structural genomic variations in breast cancer cells. 
Han Cao (Bionanomatrix, Philadelphia, USA) presented 
a  new  form  of  the  nanochannel  fluid  array/optical 
mapping technology. The suggested utility of these two 
optical mapping technologies in future clinical practice 
for  detection  of  diseases  (such  as  cancer)  that  are 
notorious for prevalent gross structural changes in the 
genome was well received.
The International Conferences of Genomics under the 
BGI’s  organization  follow  Deng  Xiaoping’s  philosophy, 
‘Developing is an unyielding principle’, which has created 
the economic miracle in mainland China for more than 
three decades. The eagerness for new ideas, technologies 
and  collaborations  aired  in  this  meeting,  as  in  all  the 
previous  four  annual  events,  has  made  it  a  unique 
opportunity to grasp new scientific concepts and initiate 
collaborative  efforts  in  large-scale  genomic  research. 
There  is  no  doubt  that  the  ICG-VI  in  2011  will  bring 
more excitement from and to all the participants.
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